ING Groep NV Acquires 28,132 Shares of Cencora, Inc. $COR

ING Groep NV boosted its holdings in shares of Cencora, Inc. (NYSE:COR) by 16.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 196,696 shares of the company’s stock after buying an additional 28,132 shares during the period. ING Groep NV owned approximately 0.10% of Cencora worth $66,434,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the business. Vestcor Inc boosted its stake in Cencora by 0.5% during the third quarter. Vestcor Inc now owns 5,196 shares of the company’s stock valued at $1,624,000 after buying an additional 28 shares during the period. JFS Wealth Advisors LLC boosted its stake in Cencora by 30.2% during the fourth quarter. JFS Wealth Advisors LLC now owns 125 shares of the company’s stock valued at $42,000 after buying an additional 29 shares during the period. Apollon Wealth Management LLC boosted its stake in Cencora by 0.5% during the fourth quarter. Apollon Wealth Management LLC now owns 6,527 shares of the company’s stock valued at $2,205,000 after buying an additional 30 shares during the period. Accent Capital Management LLC boosted its stake in Cencora by 36.1% during the fourth quarter. Accent Capital Management LLC now owns 113 shares of the company’s stock valued at $38,000 after buying an additional 30 shares during the period. Finally, MCF Advisors LLC boosted its stake in Cencora by 11.0% during the fourth quarter. MCF Advisors LLC now owns 303 shares of the company’s stock valued at $102,000 after buying an additional 30 shares during the period. Institutional investors own 97.52% of the company’s stock.

Wall Street Analyst Weigh In

COR has been the subject of several research analyst reports. William Blair initiated coverage on Cencora in a research note on Tuesday, April 28th. They set a “market perform” rating for the company. UBS Group raised their price target on Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a research report on Thursday, May 7th. Wells Fargo & Company lowered their price target on Cencora from $429.00 to $331.00 and set an “overweight” rating on the stock in a research report on Monday, May 11th. Evercore set a $360.00 price target on Cencora in a research report on Wednesday, April 8th. Finally, Weiss Ratings downgraded Cencora from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, May 22nd. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $380.25.

Cencora Trading Up 1.7%

NYSE COR opened at $274.94 on Friday. The stock’s 50-day simple moving average is $292.70 and its two-hundred day simple moving average is $330.55. Cencora, Inc. has a twelve month low of $244.82 and a twelve month high of $377.54. The company has a quick ratio of 0.59, a current ratio of 0.95 and a debt-to-equity ratio of 3.40. The company has a market capitalization of $53.49 billion, a price-to-earnings ratio of 21.08, a PEG ratio of 1.48 and a beta of 0.59.

Cencora (NYSE:COR) last released its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 EPS for the quarter, missing the consensus estimate of $4.82 by ($0.07). The company had revenue of $78.36 billion during the quarter, compared to analysts’ expectations of $81.09 billion. Cencora had a return on equity of 135.20% and a net margin of 0.78%.The firm’s quarterly revenue was up 3.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $4.42 EPS. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Research analysts forecast that Cencora, Inc. will post 17.79 EPS for the current fiscal year.

Cencora Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were issued a $0.60 dividend. The ex-dividend date was Friday, May 15th. This represents a $2.40 annualized dividend and a dividend yield of 0.9%. Cencora’s payout ratio is currently 18.40%.

Cencora declared that its board has approved a stock buyback program on Thursday, May 21st that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the company to buy up to 3.9% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company’s management believes its shares are undervalued.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.